A conceptually similar paper by another MIT economist looked at how the IP protection afforded to different genes at the time of sequencing affected follow-on research. Genens that were immediately in the public domain stimulated about about 20-30% more research/product development than comparable Celera-sequence genes that had IP protection. The paper is here: http://economics.mit.edu/files/6803